Brampton Civic Hospital is an acute care hospital in Brampton, Ontario and part of the William Osler Health System. It is a community teaching hospital for the Michael G. DeGroote School of Medicine of McMaster University.

There are 608 beds in William Osler Health System Brampton Civic Hospital.

During the past decade, William Osler Health System Brampton Civic Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "William Osler Health System Brampton Civic Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Gilead Sciences" with 3 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "University Health Network, Toronto" with 2 trials sponsored and "C. R. Bard" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "William Osler Health System Brampton Civic Hospital" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator and "Arch Biopartners Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "William Osler Health System Brampton Civic Hospital" are "COVID-19" (2 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials) and "Ann Arbor Stage III Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "William Osler Health System Brampton Civic Hospital" in a lesser frequency.

Most popular intervention types in "William Osler Health System Brampton Civic Hospital" are "Drug" (16 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Computed Tomography" (2 trials), "Dexamethasone" (2 trials) and "Magnetic Resonance Imaging" (2 trials). Other intervention names were less common.

The vast majority of trials in "William Osler Health System Brampton Civic Hospital" are 20 trials for "All" genders.

Currently, there are NaN active trials in "William Osler Health System Brampton Civic Hospital". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in William Osler Health System Brampton Civic Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in William Osler Health System Brampton Civic Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".